Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating stereotactic focal radiotherapy as an alternative to active surveillance for low- and intermediate-ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Liege | Conditions: Macroscopic Tumor Visualized at MRI, Tumor Size Allowing Partial Prostate Treatment Volume | Phase 2 | Status: NOT_YET_RECRUITING